Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 146136, 10 pages
http://dx.doi.org/10.1155/2013/146136
Research Article

Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/β-Catenin Signaling and Apoptosis Induction

1Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan
2Center of Excellence for Cancer Research, Taipei Medical University, Taipei 11031, Taiwan
3National Institute of Cancer Research, National Health Research Institutes, Miaoli 35053, Taiwan
4Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei 23561, Taiwan
5Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei 11031, Taiwan
6Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan
7Department of Otolaryngology, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan
8Department of Traditional Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan
9Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, No. 250, Wu-Hsing Street, Taipei 11031, Taiwan

Received 18 December 2012; Accepted 12 March 2013

Academic Editor: Ching-Liang Hsieh

Copyright © 2013 Chih-Jung Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Zhang, Y. Zhang, L. Mao, Z. Zhang, and W. Chen, “Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes,” Cancer Letters, vol. 277, no. 2, pp. 227–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Vermorken, E. Remenar, C. van Herpen et al., “Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer,” The New England Journal of Medicine, vol. 357, no. 17, pp. 1695–1704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. D. Silva, A. Ferlito, R. P. Takes et al., “Advances and applications of oral cancer basic research,” Oral Oncology, vol. 47, no. 9, pp. 783–791, 2011. View at Google Scholar
  4. H. T. Chien, C. T. Liao, S. F. Huang et al., “Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas,” Genes Chromosomes & Cancer, vol. 50, no. 5, pp. 358–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Arbiser, “Why targeted therapy hasn't worked in advanced cancer,” The Journal of Clinical Investigation, vol. 117, no. 10, pp. 2762–2765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Pardal, M. F. Clarke, and S. J. Morrison, “Applying the principles of stem-cell biology to cancer,” Nature Reviews Cancer, vol. 3, no. 12, pp. 895–902, 2003. View at Google Scholar · View at Scopus
  8. P. A. Beachy, S. S. Karhadkar, and D. M. Berman, “Tissue repair and stem cell renewal in carcinogenesis,” Nature, vol. 432, no. 7015, pp. 324–331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Clevers, “The cancer stem cell: premises, promises and challenges,” Nature Medicine, vol. 17, no. 3, pp. 313–319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Monroe, E. C. Anderson, D. R. Clayburgh, and M. H. Wong, “Cancer stem cells in head and neck squamous cell carcinoma,” Journal of Oncology, vol. 2011, Article ID 762780, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Dean, T. Fojo, and S. Bates, “Tumour stem cells and drug resistance,” Nature Reviews Cancer, vol. 5, no. 4, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Wu and B. A. Alman, “Side population cells in human cancers,” Cancer Letters, vol. 268, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. E. Fried and J. L. Arbiser, “Honokiol, a multifunctional antiangiogenic and antitumor agent,” Antioxidants & Redox Signaling, vol. 11, no. 5, pp. 1139–1148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Q. Jiang, L. Y. Fan, G. L. Yang et al., “Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model,” BMC Cancer, vol. 8, article 242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Wolf, J. O'Kelly, N. Wakimoto et al., “Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest,” International Journal of Oncology, vol. 30, no. 6, pp. 1529–1537, 2007. View at Google Scholar · View at Scopus
  16. E. R. Hahm and S. V. Singh, “Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity,” Molecular Cancer Therapeutics, vol. 6, no. 10, pp. 2686–2695, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Chen, T. Wang, Y. F. Wu et al., “Honokiol: a potent chemotherapy candidate for human colorectal carcinoma,” World Journal of Gastroenterology, vol. 10, no. 23, pp. 3459–3463, 2004. View at Google Scholar · View at Scopus
  18. X. Bai, F. Cerimele, M. Ushio-Fukai et al., “Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo,” The Journal of Biological Chemistry, vol. 278, no. 37, pp. 35501–35507, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Sheu, S. H. Liu, and K. H. Lan, “Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth,” PLoS One, vol. 2, no. 10, Article ID e1096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Shigemura, J. L. Arbiser, S. Y. Sun et al., “Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells,” Cancer, vol. 109, no. 7, pp. 1279–1289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. R. Hahm, J. A. Arlotti, S. W. Marynowski, and S. V. Singh, “Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction,” Clinical Cancer Research, vol. 14, no. 4, pp. 1248–1257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Leeman-Neill, Q. Cai, S. C. Joyce et al., “Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors,” Clinical Cancer Research, vol. 16, no. 9, pp. 2571–2579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. X. R. Chen, R. Lu, H. X. Dan et al., “Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells,” International Journal of Oral Science, vol. 3, no. 1, pp. 34–42, 2011. View at Google Scholar · View at Scopus
  24. C. Chen, Y. Wei, M. Hummel et al., “Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma,” PLoS One, vol. 6, no. 1, Article ID e16466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Bao, Z. Wang, S. Ali et al., “Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells,” Cancer Letters, vol. 307, no. 1, pp. 26–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Takahashi-Yanaga and M. Kahn, “Targeting Wnt signaling: can we safely eradicate cancer stem cells?” Clinical Cancer Research, vol. 16, no. 12, pp. 3153–3162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. W. Lin, M. Y. Liao, W. W. Lin, Y. P. Wang, T. Y. Lu, and H. C. Wu :, “Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer,” The Journal of Biological Chemistry, vol. 287, no. 47, pp. 39449–39459, 2012. View at Google Scholar
  28. O. Felthaus, T. Ettl, M. Gosau et al., “Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines,” Biochemical and Biophysical Research Communications, vol. 407, no. 1, pp. 28–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Zhang, H. Xi, A. Cai et al., “Not all side population cells contain cancer stem-like cells in human gastric cancer cell lines,” Digestive Diseases and Sciences, vol. 58, no. 1, pp. 132–139, 2013. View at Google Scholar
  30. T. Efferth, “Stem cells, cancer stem-like cells, and natural products,” Planta Medica, vol. 78, no. 10, pp. 935–942, 2012. View at Google Scholar
  31. S. Ponnurangam, J. M. Mammen, S. Ramalingam et al., “Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells,” Molecular Cancer Therapeutics, vol. 11, no. 4, pp. 963–972, 2012. View at Google Scholar
  32. S. Ziegler, S. Rohrs, L. Tickenbrock et al., “Novel target genes of the Wnt pathway and statistical insights into Wnt target promoter regulation,” The FEBS Journal, vol. 272, no. 7, pp. 1600–1615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Zeilstra, S. P. J. Joosten, M. Dokter, E. Verwiel, M. Spaargaren, and S. T. Pals, “Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis,” Cancer Research, vol. 68, no. 10, pp. 3655–3661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Galichon and A. Hertig, “Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside?” Fibrogenesis & Tissue Repair, vol. 4, no. 1, article 11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Liu, “New insights into epithelial-mesenchymal transition in kidney fibrosis,” Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 212–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Conacci-Sorrell, I. Simcha, T. Ben-Yedidia, J. Blechman, P. Savagner, and A. Ben-Ze'Ev, “Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK,” The Journal of Cell Biology, vol. 163, no. 4, pp. 847–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. A. Mani, W. Guo, M. J. Liao et al., “The epithelial-mesenchymal transition generates cells with properties of stem cells,” Cell, vol. 133, no. 4, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Hayashida, H. Jinno, Y. Kitagawa, and M. Kitajima, “Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis,” Journal of Oncology, vol. 2011, Article ID 591427, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Turner and M. Kohandel, “Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: a mathematical approach,” Journal of Theoretical Biology, vol. 265, no. 3, pp. 329–335, 2010. View at Publisher · View at Google Scholar · View at Scopus